Trial intelligence / Profile preview

Fluid therapy in acute diabetic ketoacidosis

2008-004049-27Phase 3Active

Sponsor
Karolinska University Hospital
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ringer's acetate and sodium chloride in diabetic ketoacidosis (DKA) (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: ICU length of stay, Time to pH > 7.3 and 1 more. Started Aug 2008; status: active.

02

Drugs

ringer's acetatesodium chloride
03

Conditions

diabetic ketoacidosis (DKA)

Beyond the preview

Go deeper on 2008-004049-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004049-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call